RSEGX
Price
$70.36
Change
+$0.86 (+1.24%)
Updated
Jun 2 closing price
Net Assets
383.38M
VSGIX
Price
$100.79
Change
+$0.72 (+0.72%)
Updated
Jun 2 closing price
Net Assets
42.8B
Interact to see
Advertisement

RSEGX vs VSGIX

Header iconRSEGX vs VSGIX Comparison
Open Charts RSEGX vs VSGIXBanner chart's image
RSEGX vs VSGIX Comparison Chart in %
View a ticker or compare two or three
VS
RSEGX vs. VSGIX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RSEGX is a Buy and VSGIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSGIX has more cash in the bank: 42.8B vs. RSEGX (383M). VSGIX pays higher dividends than RSEGX: VSGIX (0.45) vs RSEGX (0.00). RSEGX was incepted earlier than VSGIX: RSEGX (39 years) vs VSGIX (26 years). RSEGX (1.41) is less costly to investors than VSGIX (0.05). RSEGX is a more actively managed with annual turnover of: 95.00 vs. VSGIX (24.00). RSEGX has a lower initial minimum investment than VSGIX: RSEGX (2500) vs VSGIX (5000000). RSEGX (35.61) and VSGIX (34.43) have marching annual gain over last year. VSGIX return over 5 years is better than : 30.87 vs. RSEGX (-24.37).
RSEGXVSGIXRSEGX / VSGIX
Total Expense Ratio1.400.052,800%
Annual Report Gross Expense Ratio1.410.052,820%
Fund Existence39 years26 years-
Gain YTD18.25817.796103%
Front Load6%N/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets383M42.8B1%
Annual Yield % from dividends0.000.45-
Returns for 1 year35.6134.43103%
Returns for 3 years47.0361.6376%
Returns for 5 years-24.3730.87-79%
Returns for 10 years16.69191.289%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ASTC45.319.91
+27.99%
Astrotech Corp
YORW29.930.40
+1.35%
York Water Company
BCC69.220.89
+1.30%
Boise Cascade Company
JZXN1.31-0.03
-2.24%
Jiuzi Holdings Inc.
BBIO63.85-1.51
-2.31%
BridgeBio Pharma